Tim Wilsdon recently presented at an education forum at ISPOR Latin America, talking about the challenges that gene therapy poses for value assessment and considerations for the future.
For more information about the conference, click here.
How to successfully commercialise microbiome-based diagnostics
In this Med-tech Innovation News article, Andrew Thomson, Brian Carpenter and Robert Broadnax explore key drivers of adoption of microbiome-based diagnostics,...